Avanos Medical Inc(AVNS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.61 | Insider Own | 2.77% | Shs Outstand | 46.7M | Perf Week | - |
| Market Cap | 1.17B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 46.3M | Perf Month | 0.28% |
| Enterprise Value | 1.24B | PEG | - | EPS next Q | - | Inst Own | 90.31% | Short Float | 3.78% | Perf Quarter | 1.09% |
| Income | -0.07B | P/S | 1.64 | EPS this Y | - | Inst Trans | -7.39% | Short Ratio | 1.6 | Perf Half Y | 79.78% |
| Sales | 0.72B | P/B | 1.49 | EPS next 5Y | - | ROA | -6.9% | Short Interest | 1.75M | Perf YTD | 122.53% |
| Book/sh | 16.76 | P/C | 17.85 | EPS past 3/5Y | - -22.58% | ROE | -9.18% | 52W High | -1.96% ($25.49) | Perf Year | 110.35% |
| Cash/sh | 1.4 | P/FCF | 156.1 | Sales past 3/5Y | 0.83% -0.38% | ROIC | -8.27% | 52W Low | 168.62% ($9.30) | Perf 3Y | -2.15% |
| Dividend Est. | - | EV/EBITDA | 16.74 | EPS Y/Y TTM | 80.78% | Gross Margin | 48.55% | Volatility(W/M) | 0.07% 0.22% | Perf 5Y | -28.09% |
| Dividend TTM | - | EV/Sales | 1.74 | Sales Y/Y TTM | 3.87% | Oper. Margin | 4.86% | ATR (14) | 0.06 | Perf 10Y | -25.51% |
| Dividend Ex-Date | - | Quick Ratio | 1.4 | EPS Q/Q | -23.83% | Profit Margin | -10.39% | RSI (14) | 62.11 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.48 | Sales Q/Q | 8.78% | SMA20 | 0.23% ($24.93) | Beta | 1.58 | Target Price | $14 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/5/5 | SMA50 | 0.37% ($24.9) | Rel Volume | 0 | Prev Close | $24.99 |
| Employees | 2287 | LT Debt/Eq | 0.15 | EPS/Sales Surpr. | 57.14% 7.18% | SMA200 | 47.72% ($16.92) | Avg Volume(3M) | 1.10M | Price | $24.99 |
| IPO | 2014/10/21 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
Avanos Medical (AVNS) is a U.S. medical device company focused on digestive health and pain management and recovery. It was spun off from Kimberly-Clark in 2014 and listed independently, supplying enteral feeding tubes, surgical pain pumps, and cold and compression therapy systems to healthcare facilities worldwide. With demand driven primarily by consumable and single-use medical devices, it is a small- to mid-cap healthcare stock with a stable demand base.
Over the past 1 year, on the higher side
2% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
AVNS keeps an operating profit but posts a net loss
Of every $100 in sales, $4.86 is kept as operating profit.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $164. Peers typically go for $314. Compared with its own 2-year average, it is 19% cheaper now.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -28.1%. The S&P 500 did +47% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 90.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #37 of 141 in the industry
Based on market cap of $1B.
FAQ
AVNS belongs to the Healthcare sector and operates in the Medical Devices industry.
The market cap of AVNS is approximately $1.2B, ranking 2,560 within its sector.
AVNS has recorded a 52-week high of $25.49 and a low of $9.30.